143 related articles for article (PubMed ID: 19875384)
1. TREX1 gene variant in neuropsychiatric systemic lupus erythematosus.
de Vries B; Steup-Beekman GM; Haan J; Bollen EL; Luyendijk J; Frants RR; Terwindt GM; van Buchem MA; Huizinga TW; van den Maagdenberg AM; Ferrari MD
Ann Rheum Dis; 2010 Oct; 69(10):1886-7. PubMed ID: 19875384
[No Abstract] [Full Text] [Related]
2. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus.
Lee-Kirsch MA; Gong M; Chowdhury D; Senenko L; Engel K; Lee YA; de Silva U; Bailey SL; Witte T; Vyse TJ; Kere J; Pfeiffer C; Harvey S; Wong A; Koskenmies S; Hummel O; Rohde K; Schmidt RE; Dominiczak AF; Gahr M; Hollis T; Perrino FW; Lieberman J; Hübner N
Nat Genet; 2007 Sep; 39(9):1065-7. PubMed ID: 17660818
[TBL] [Abstract][Full Text] [Related]
3. A homozygote TREX1 mutation in two siblings with different phenotypes: Chilblains and cerebral vasculitis.
Kisla Ekinci RM; Balci S; Bisgin A; Altintas DU; Yilmaz M
Eur J Med Genet; 2017 Dec; 60(12):690-694. PubMed ID: 28919362
[TBL] [Abstract][Full Text] [Related]
4. Identification of a pathogenic variant in TREX1 in early-onset cerebral systemic lupus erythematosus by Whole-exome sequencing.
Ellyard JI; Jerjen R; Martin JL; Lee AY; Field MA; Jiang SH; Cappello J; Naumann SK; Andrews TD; Scott HS; Casarotto MG; Goodnow CC; Chaitow J; Pascual V; Hertzog P; Alexander SI; Cook MC; Vinuesa CG
Arthritis Rheumatol; 2014 Dec; 66(12):3382-6. PubMed ID: 25138095
[TBL] [Abstract][Full Text] [Related]
5. Familial chilblain lupus--a monogenic form of cutaneous lupus erythematosus due to a heterozygous mutation in TREX1.
Günther C; Meurer M; Stein A; Viehweg A; Lee-Kirsch MA
Dermatology; 2009; 219(2):162-6. PubMed ID: 19478477
[TBL] [Abstract][Full Text] [Related]
6. Systemic involvement in TREX1-associated familial chilblain lupus.
Günther C; Hillebrand M; Brunk J; Lee-Kirsch MA
J Am Acad Dermatol; 2013 Oct; 69(4):e179-81. PubMed ID: 24034389
[No Abstract] [Full Text] [Related]
7. TREX1 mutations are not associated with sporadic inclusion body myositis.
Cox FM; Boon EM; van der Lans CA; Bakker E; Verschuuren JJ; Badrising UA
Eur J Neurol; 2010 Aug; 17(8):1108-9. PubMed ID: 20192983
[TBL] [Abstract][Full Text] [Related]
8. Familial chilblain lupus due to a novel mutation in the exonuclease III domain of 3' repair exonuclease 1 (TREX1).
Günther C; Berndt N; Wolf C; Lee-Kirsch MA
JAMA Dermatol; 2015 Apr; 151(4):426-31. PubMed ID: 25517357
[TBL] [Abstract][Full Text] [Related]
9. Inherited or de novo mutation affecting aspartate 18 of TREX1 results in either familial chilblain lupus or Aicardi-Goutières syndrome.
Tüngler V; Silver RM; Walkenhorst H; Günther C; Lee-Kirsch MA
Br J Dermatol; 2012 Jul; 167(1):212-4. PubMed ID: 22356656
[No Abstract] [Full Text] [Related]
10. Dysregulation of the immune system in Aicardi-Goutières syndrome: another example in a TREX1-mutated patient.
Olivieri I; Cattalini M; Tonduti D; La Piana R; Uggetti C; Galli J; Meini A; Tincani A; Moratto D; Fazzi E; Balottin U; Orcesi S
Lupus; 2013 Sep; 22(10):1064-9. PubMed ID: 23918923
[TBL] [Abstract][Full Text] [Related]
11. Heterozygous TREX1 p.Asp18Asn mutation can cause variable neurological symptoms in a family with Aicardi-Goutieres syndrome/familial chilblain lupus.
Abe J; Izawa K; Nishikomori R; Awaya T; Kawai T; Yasumi T; Hiragi N; Hiragi T; Ohshima Y; Heike T
Rheumatology (Oxford); 2013 Feb; 52(2):406-8. PubMed ID: 22829693
[No Abstract] [Full Text] [Related]
12. Clinical images: Neuropsychiatric systemic lupus erythematosus.
Zapor M; Rennie T; Murphy FT; Battafarano DF
Arthritis Rheum; 2000 Sep; 43(9):2045. PubMed ID: 11014355
[No Abstract] [Full Text] [Related]
13. Heterozygous mutations in TREX1 cause familial chilblain lupus and dominant Aicardi-Goutieres syndrome.
Rice G; Newman WG; Dean J; Patrick T; Parmar R; Flintoff K; Robins P; Harvey S; Hollis T; O'Hara A; Herrick AL; Bowden AP; Perrino FW; Lindahl T; Barnes DE; Crow YJ
Am J Hum Genet; 2007 Apr; 80(4):811-5. PubMed ID: 17357087
[TBL] [Abstract][Full Text] [Related]
14. [Neurological disorders in systemic lupus erythematosus patients].
Hawro T; Bogucki A; Sysa-Jedrzejowska A; Bogaczewicz J; Woźniacka A
Pol Merkur Lekarski; 2009 Jan; 26(151):43-8. PubMed ID: 19391506
[TBL] [Abstract][Full Text] [Related]
15. SLEB3 in systemic lupus erythematosus (SLE) is strongly related to SLE families ascertained through neuropsychiatric manifestations.
Nath SK; Kelly JA; Reid J; Lam T; Gray-McGuire C; Namjou B; Aston CE; Harley JB
Hum Genet; 2002 Jul; 111(1):54-8. PubMed ID: 12136236
[TBL] [Abstract][Full Text] [Related]
16. Human disease phenotypes associated with mutations in TREX1.
Rice GI; Rodero MP; Crow YJ
J Clin Immunol; 2015 Apr; 35(3):235-43. PubMed ID: 25731743
[TBL] [Abstract][Full Text] [Related]
17. [Characteristic manifestations of neuropsychiatric systemic lupus erythematosus].
Liu Z; Chen L; Cui LY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Aug; 27(4):509-12. PubMed ID: 16178450
[TBL] [Abstract][Full Text] [Related]
18. Biochemical properties of mammalian TREX1 and its association with DNA replication and inherited inflammatory disease.
Lindahl T; Barnes DE; Yang YG; Robins P
Biochem Soc Trans; 2009 Jun; 37(Pt 3):535-8. PubMed ID: 19442247
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in TREX1 and susceptibility to HIV-1 infection.
Pontillo A; Girardelli M; Catamo E; Duarte AJ; Crovella S
Int J Immunogenet; 2013 Dec; 40(6):492-4. PubMed ID: 23773365
[TBL] [Abstract][Full Text] [Related]
20. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
